Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Replimune Group, Inc. Director's Dealing 2020

Apr 3, 2020

33193_dirs_2020-04-03_6ab46d56-b219-484e-9ab7-c360859f719c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2020-04-01

Reporting Person: Omega Fund IV, L.P. (Director, 10% Owner)
Reporting Person: Omega Fund IV GP, L.P. (10% Owner)
Reporting Person: Omega Fund IV G.P. Manager, Ltd. (10% Owner)
Reporting Person: Stampacchia Otello (10% Owner)
Reporting Person: Paster Anne-Mari (10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-04-01 Stock Option (Right to Buy) $9.78 A 16500 Acquired Common Stock (16500) Direct

Footnotes

F1: The Common Stock Options (the "Options") were granted to Otello Stampacchia in his capacity as a director of the issuer on April 1, 2020 (the "Grant Date"), with the Options vesting on the first anniversary of the Grant Date. The Options expire on the tenth anniversary of the Grant Date. The Options are held directly by Mr. Stampacchia.